EPO Patents = 1

Forward Citations = 54

Loading Chart...

4 inventors (with patents filed for the assignee):

Michael P McKenna (6 out of 12 patents)

Michael S Urdea (6 out of 63 patents)

Patrick A Arensdorf (3 out of 17 patents)

4. Scott Eastman (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 8409816 - Diabetes-related biomarkers and methods of use thereof (2013-04-02),

2. 8357497 - Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets (2013-01-22),

3. 8232065 - Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets (2012-07-31),

4. 8119358 - Diabetes-related biomarkers and methods of use thereof (2012-02-21),

5. 8097425 - Multiplex protein fractionation (2012-01-17),

6. 7723050 - Diabetes-related biomarkers and methods of use thereof (2010-05-25),

Tethys Bioscience, Inc. offers personalized medicine solutions for individuals at risk for chronic conditions such as diabetes and cardiovascular disease. With a focus on preventive healthcare, the company utilizes advanced molecular diagnostics to provide actionable insights for early intervention and treatment. Tethys Bioscience is committed to improving health outcomes and reducing healthcare costs through precision medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

6 Patents

#74 in Emeryville, CA

#10,297 in California

#43,823 in US

Emeryville, CA, United States of America

Tethys Bioscience, Inc.

Forward Citations = 54

4 inventors:

Michael P McKenna (6 out of 12 patents)

Michael S Urdea (6 out of 63 patents)

Patrick A Arensdorf (3 out of 17 patents)

4. Scott Eastman (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com